Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
about
Resisting resistance: is there a solution for malaria?Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.The advancement of multidimensional QSAR for novel drug discovery - where are we headed?Recent Developments in Antimicrobial Polymers: A Review.Synthesis and antimicrobial activity of binaphthyl-based, functionalized oxazole and thiazole peptidomimetics.Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique.Antimicrobial Nanoplexes meet Model Bacterial Membranes: the key role of Cardiolipin.
P2860
Q38755043-DFC8DCF8-F0B8-44D6-B0DC-A4B2EB444D82Q38949284-63F48B7E-8078-4459-9719-FF8325632378Q39340690-94B07D09-1721-4BF1-A8E5-013B87185EBDQ40107966-814C065C-E51D-48A8-B693-61F40D2551C3Q41010306-BBFF9DB5-1312-4CDC-842C-A81B24DEF6FCQ41815282-D9930D80-DFD2-4D05-BB1B-2AE522C09DEBQ41839313-2494CC77-898D-4C97-A705-D327A9026307
P2860
Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Designing drugs that overcome ...... e stand and what should we do?
@en
type
label
Designing drugs that overcome ...... e stand and what should we do?
@en
prefLabel
Designing drugs that overcome ...... e stand and what should we do?
@en
P2860
P1476
Designing drugs that overcome ...... e stand and what should we do?
@en
P2093
Martina Traykovska
P2860
P304
P356
10.1517/17460441.2015.1048219
P407
P577
2015-05-18T00:00:00Z